Post job

Synspira Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Robert Gallotto is the Synspira Therapeutics's CEO. Synspira Therapeutics has 30 employees, of which 6 are in a leadership position.
Work at Synspira Therapeutics?
Share your experience

Rate Synspira Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Robert Gallotto

CEO, President, Executive

Robert Gallotto's LinkedIn

Robert Gallotto is a President and Chief Executive Officer at Synspira LLC and is based in Framingham, Massachusetts. He has experience at Serono Inc and has worked as Vice President of Strategic Planning & Business & Commercial Development at Altus Technologies Corporation, Various Positions at Biogen Idec, and Sales at Pfizer. Robert attended Stonehill College between 1983 and 1987 and Dom Savio between 1979 and 1983.

Shenda Baker

Board Member

Andrew W. Miller

Board Member

Glenn Batchelder

Board Member

Gregory Fiore M.D.

Chief Medical Officer / Medical Advisor

Gregory Fiore M.D.'s LinkedIn

Harvard trained MD, biotech CEO / CMO, entrepreneur (co-founder and CEO of Exacis Biotherapeutics and former CEO of Sollis Therapeutics; founder at Fiore Healthcare & SSI Strategy), former McKinsey and angel investor (healthcare, media, consumer products).Business Leadership and Business Development:Former founder and CEO of Sollis Therapeutics, former management consultant (McKinsey and Company) and founder of two pharmaceutical consultancies (Fiore Healthcare Advisors and SSI Strategy). Former BD role and head of Alliance Management. Extensive diligence experience for both single assets and corporate acquisition targets. Clinical Research: CMO at development and commercial stage biopharma companies; experience in CV/Renal, intensive care medicine, rare diseases [cystic fibrosis], analgesia, anti-infective, research governance. Drug Safety/PV: Head of Safety or external head for more than 10 companies; safety governance, PV system and QMS design; many successful health authority inspections and responses; global safety database owner; extensive outsourcing/offshoring experience with focus on quality.Benefit / Risk Management: CV, anesthesia/critical care, neuroscience, women’s health, bone, inflammation/autoimmune, oncology, ophthalmology, endocrine, respiratory, dermatology, GI; PSUR/PBRER.Medical Affairs: Launch planning - MSL and Med Info strategy; HCP and institutional education approaches; voice of customer capture; publications; Phase IV, grants and promotional review.

William Wiesmann

Board Member

Do you work at Synspira Therapeutics?

Does the leadership team provide a clear direction for Synspira Therapeutics?

Synspira Therapeutics jobs

Synspira Therapeutics founders

Name & TitleBio
Robert Gallotto

CEO, President, Executive

Robert Gallotto's LinkedIn

Robert Gallotto is a President and Chief Executive Officer at Synspira LLC and is based in Framingham, Massachusetts. He has experience at Serono Inc and has worked as Vice President of Strategic Planning & Business & Commercial Development at Altus Technologies Corporation, Various Positions at Biogen Idec, and Sales at Pfizer. Robert attended Stonehill College between 1983 and 1987 and Dom Savio between 1979 and 1983.

Shenda Baker

Board Member

Synspira Therapeutics board members

Name & TitleBio
Shenda Baker

Board Member

Andrew W. Miller

Board Member

Glenn Batchelder

Board Member

William Wiesmann

Board Member

Synspira Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Synspira Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Synspira Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Synspira Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Synspira Therapeutics. The data presented on this page does not represent the view of Synspira Therapeutics and its employees or that of Zippia.

Synspira Therapeutics may also be known as or be related to Synspira, Synspira LLC, Synspira Therapeutics and Synspira, LLC.